691 related articles for article (PubMed ID: 30894861)
21. CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.
Santoni M; Bracarda S; Nabissi M; Massari F; Conti A; Bria E; Tortora G; Santoni G; Cascinu S
Biomed Res Int; 2014; 2014():768758. PubMed ID: 24971349
[TBL] [Abstract][Full Text] [Related]
22. Targeting the chemokine network in atherosclerosis.
Yan Y; Thakur M; van der Vorst EPC; Weber C; Döring Y
Atherosclerosis; 2021 Aug; 330():95-106. PubMed ID: 34247863
[TBL] [Abstract][Full Text] [Related]
23. The chemokine system and its contribution to leukemogenesis and treatment responsiveness in patients with acute myeloid leukemia.
Olsnes AM; Hatfield KJ; Bruserud Ø
J BUON; 2009 Sep; 14 Suppl 1():S131-40. PubMed ID: 19785055
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.
Luo Y; Chen X; O'Donnell MA
Clin Exp Immunol; 2007 Feb; 147(2):370-8. PubMed ID: 17223980
[TBL] [Abstract][Full Text] [Related]
25. Antichemokine immunotherapy for allergic diseases.
Luster AD
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):561-7. PubMed ID: 11964742
[TBL] [Abstract][Full Text] [Related]
26. Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).
Nomura T; Hasegawa H
Anticancer Res; 2000; 20(6A):4073-80. PubMed ID: 11131675
[TBL] [Abstract][Full Text] [Related]
27. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation.
Pinto S; Martínez-Romero A; O'Connor JE; Gil-Benso R; San-Miguel T; Terrádez L; Monteagudo C; Callaghan RC
BMC Cancer; 2014 Feb; 14():118. PubMed ID: 24559071
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
[TBL] [Abstract][Full Text] [Related]
29. Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions.
Pokkali S; Das SD; R L
Cytokine; 2008 Mar; 41(3):307-14. PubMed ID: 18226915
[TBL] [Abstract][Full Text] [Related]
30. Chemokines in tumor immunotherapy.
Flanagan K; Kaufman HL
Front Biosci; 2006 Jan; 11():1024-30. PubMed ID: 16146794
[TBL] [Abstract][Full Text] [Related]
31. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
32. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
33. Chemokine-based immunotherapy: delivery systems and combination therapies.
Mohit E; Rafati S
Immunotherapy; 2012 Aug; 4(8):807-40. PubMed ID: 22947009
[TBL] [Abstract][Full Text] [Related]
34. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness).
Hall LR; Diaconu E; Patel R; Pearlman E
J Immunol; 2001 Mar; 166(6):4035-41. PubMed ID: 11238651
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
36. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor expressions and responsiveness of cord blood T cells.
Sato K; Kawasaki H; Nagayama H; Enomoto M; Morimoto C; Tadokoro K; Juji T; Takahashi T
J Immunol; 2001 Feb; 166(3):1659-66. PubMed ID: 11160208
[TBL] [Abstract][Full Text] [Related]
39. Chemokines and receptors in HIV encephalitis.
Sanders VJ; Pittman CA; White MG; Wang G; Wiley CA; Achim CL
AIDS; 1998 Jun; 12(9):1021-6. PubMed ID: 9662198
[TBL] [Abstract][Full Text] [Related]
40. Atypical chemokine receptors in cancer: friends or foes?
Massara M; Bonavita O; Mantovani A; Locati M; Bonecchi R
J Leukoc Biol; 2016 Jun; 99(6):927-33. PubMed ID: 26908826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
